AMARIN CORP PLC\UK Other Current Assets
AMARIN CORP PLC\UK (AMRN) had Other Current Assets of $2.63 million as of 2014-12-31, per its 10-K filed 2015-03-03.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2015-03-03
- 2014-12-31: Other Assets, Current $2.63M.
- 2014-09-30: Other Assets, Current $2.98M.
- 2014-06-30: Other Assets, Current $2.88M.
- 2014-03-31: Other Assets, Current $2.94M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2014-12-31 | $2.63M 10-K · filed 2015-03-03 | |
| 2014-09-30 | $2.98M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $2.88M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $2.94M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $1.56M 10-K · filed 2015-03-03 | |
| 2013-09-30 | $3.54M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $2.17M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $7.05M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $3.25M 10-K · filed 2014-02-27 | |
| 2012-09-30 | $4.11M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $6.43M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $4.97M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $1.84M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $2.21M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $1.14M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $1.06M 10-K · filed 2012-02-29 | $1.67M 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |